COMPLETE TEST BANK FOR
PSYCHOPHARMACOLOGY DRUGS THE BRAIN
AND BEHAVIOR 4TH EDITION BY JERRY MEYER
,COMPLETE TEST BANK FOR
PSYCHOPHARMACOLOGY DRUGS THE BRAIN
AND BEHAVIOR 4TH EDITION BY JERRY MEYER
Table of Contents
CHAPTER 1: PRINCIPLES OF PHARMACOLOGY 3
CHAPTER 2: STRUCTURE AND FUNCTION OF THE NERVOUS SYSTEM 20
CHAPTER 3: CHEMICAL SIGNALING BY NEUROTRANSMITTERS AND HORMONES 36
CHAPTER 4: METHODS OF RESEARCH IN PSYCHOPHARMACOLOGY 53
CHAPTER 5: CATECHOLAMINES 73
CHAPTER 6: SEROTONIN 90
CHAPTER 7: ACETYLCHOLINE 108
CHAPTER 8: GLUTAMATE AND GABA 124
CHAPTER 9: DRUG ABUSE AND ADDICTION 140
CHAPTER 10: ALCOHOL 158
CHAPTER 11: THE OPIOIDS 174
CHAPTER 12: PSYCHOMOTOR STIMULANTS: COCAINE AND THE AMPHETAMINES 194
CHAPTER 13: NICOTINE AND CAFFEINE 217
CHAPTER 14: MARIJUANA AND THE CANNABINOIDS 235
CHAPTER 15: HALLUCINOGENS, PCP, AND KETAMINE 255
CHAPTER 16: INHALANTS, GHB, AND ANABOLIC–ANDROGENIC STEROIDS 272
CHAPTER 17: DISORDERS OF ANXIETY AND IMPULSIVITY AND THE DRUGS USED TO TREAT THESE 290
,CHAPTER 18: AFFECTIVE DISORDERS: ANTIDEPRESSANTS AND MOOD STABILIZERS 310
CHAPTER 19: SCHIZOPHRENIA: ANTIPSYCHOTIC DRUGS 329
CHAPTER 20: NEURODEGENERATIVE DISORDERS349
COMPLETE TEST BANK FOR PSYCHOPHARMACOLOGY DRUGS THE BRAIN AND BEHAVIOR 4TH EDITION
BY JERRY MEYER
CHAPTER 1: PRINCIPLES OF PHARMACOLOGY
MULTIPLE CHOICE
1. REFER(S) TO SPECIFIC MOLECULAR CHANGES THAT OCCUR WHEN A DRUG BINDS TO A
PARTICULAR TARGET SITE OR RECEPTOR, WHILE ARE THE RESULTING WIDESPREAD ALTERATIONS IN
FUNCTION.
A. DRUG ACTION; THERAPEUTIC EFFECTS
B. SIDE EFFECTS; DRUG EFFECTS
C. THERAPEUTIC EFFECTS; SIDE EFFECTS
D. DRUG ACTION; DRUG EFFECTS
ANSWER: D
TEXTBOOK REFERENCE: PHARMACOLOGY: THE SCIENCE OF DRUG ACTION
2. AFTER DRUG ADMINISTRATION HAS OCCURRED, THE AMOUNT OF DRUG IN THE BLOOD THAT IS
FREE TO BIND AT SPECIFIC TARGET SITES IS REFERRED TO AS
A. THE THERAPEUTIC DOSE.
B. FIRST-PASS EFFECTS.
C. BIOAVAILABILITY.
D. ED50.
ANSWER: C
TEXTBOOK REFERENCE: PHARMACOKINETIC FACTORS DETERMINING DRUG ACTION
, 3. THE SPECIFIC MOLECULAR CHANGES THAT OCCUR WHEN A DRUG BINDS TO A PARTICULAR
TARGET SITE OR RECEPTOR ARE REFERRED TO AS
A. DRUG EFFECTS.
B. DRUG ACTION.
C. SIDE EFFECTS.
D. PLACEBO EFFECTS.
ANSWER: B
TEXTBOOK REFERENCE: PHARMACOLOGY: THE SCIENCE OF DRUG ACTION
4. WHICH OF THE FOLLOWING IS NOT A POSSIBLE EXPLANATION FOR PLACEBO EFFECTS?
A. PAVLOVIAN CONDITIONING
B. GENETIC VARIATION
C. DRUG COMPETITION
D. EXPECTATION OF OUTCOME
ANSWER: C
TEXTBOOK REFERENCE: PHARMACOLOGY: THE SCIENCE OF DRUG ACTION
OM
PAGE 1 OF 247
5. THE ADMINISTRATION OF OXYTOCIN HAS BEEN PROPOSED AS A TREATMENT FOR AUTISM.
PSYCHOPHARMACOLOGY DRUGS THE BRAIN
AND BEHAVIOR 4TH EDITION BY JERRY MEYER
,COMPLETE TEST BANK FOR
PSYCHOPHARMACOLOGY DRUGS THE BRAIN
AND BEHAVIOR 4TH EDITION BY JERRY MEYER
Table of Contents
CHAPTER 1: PRINCIPLES OF PHARMACOLOGY 3
CHAPTER 2: STRUCTURE AND FUNCTION OF THE NERVOUS SYSTEM 20
CHAPTER 3: CHEMICAL SIGNALING BY NEUROTRANSMITTERS AND HORMONES 36
CHAPTER 4: METHODS OF RESEARCH IN PSYCHOPHARMACOLOGY 53
CHAPTER 5: CATECHOLAMINES 73
CHAPTER 6: SEROTONIN 90
CHAPTER 7: ACETYLCHOLINE 108
CHAPTER 8: GLUTAMATE AND GABA 124
CHAPTER 9: DRUG ABUSE AND ADDICTION 140
CHAPTER 10: ALCOHOL 158
CHAPTER 11: THE OPIOIDS 174
CHAPTER 12: PSYCHOMOTOR STIMULANTS: COCAINE AND THE AMPHETAMINES 194
CHAPTER 13: NICOTINE AND CAFFEINE 217
CHAPTER 14: MARIJUANA AND THE CANNABINOIDS 235
CHAPTER 15: HALLUCINOGENS, PCP, AND KETAMINE 255
CHAPTER 16: INHALANTS, GHB, AND ANABOLIC–ANDROGENIC STEROIDS 272
CHAPTER 17: DISORDERS OF ANXIETY AND IMPULSIVITY AND THE DRUGS USED TO TREAT THESE 290
,CHAPTER 18: AFFECTIVE DISORDERS: ANTIDEPRESSANTS AND MOOD STABILIZERS 310
CHAPTER 19: SCHIZOPHRENIA: ANTIPSYCHOTIC DRUGS 329
CHAPTER 20: NEURODEGENERATIVE DISORDERS349
COMPLETE TEST BANK FOR PSYCHOPHARMACOLOGY DRUGS THE BRAIN AND BEHAVIOR 4TH EDITION
BY JERRY MEYER
CHAPTER 1: PRINCIPLES OF PHARMACOLOGY
MULTIPLE CHOICE
1. REFER(S) TO SPECIFIC MOLECULAR CHANGES THAT OCCUR WHEN A DRUG BINDS TO A
PARTICULAR TARGET SITE OR RECEPTOR, WHILE ARE THE RESULTING WIDESPREAD ALTERATIONS IN
FUNCTION.
A. DRUG ACTION; THERAPEUTIC EFFECTS
B. SIDE EFFECTS; DRUG EFFECTS
C. THERAPEUTIC EFFECTS; SIDE EFFECTS
D. DRUG ACTION; DRUG EFFECTS
ANSWER: D
TEXTBOOK REFERENCE: PHARMACOLOGY: THE SCIENCE OF DRUG ACTION
2. AFTER DRUG ADMINISTRATION HAS OCCURRED, THE AMOUNT OF DRUG IN THE BLOOD THAT IS
FREE TO BIND AT SPECIFIC TARGET SITES IS REFERRED TO AS
A. THE THERAPEUTIC DOSE.
B. FIRST-PASS EFFECTS.
C. BIOAVAILABILITY.
D. ED50.
ANSWER: C
TEXTBOOK REFERENCE: PHARMACOKINETIC FACTORS DETERMINING DRUG ACTION
, 3. THE SPECIFIC MOLECULAR CHANGES THAT OCCUR WHEN A DRUG BINDS TO A PARTICULAR
TARGET SITE OR RECEPTOR ARE REFERRED TO AS
A. DRUG EFFECTS.
B. DRUG ACTION.
C. SIDE EFFECTS.
D. PLACEBO EFFECTS.
ANSWER: B
TEXTBOOK REFERENCE: PHARMACOLOGY: THE SCIENCE OF DRUG ACTION
4. WHICH OF THE FOLLOWING IS NOT A POSSIBLE EXPLANATION FOR PLACEBO EFFECTS?
A. PAVLOVIAN CONDITIONING
B. GENETIC VARIATION
C. DRUG COMPETITION
D. EXPECTATION OF OUTCOME
ANSWER: C
TEXTBOOK REFERENCE: PHARMACOLOGY: THE SCIENCE OF DRUG ACTION
OM
PAGE 1 OF 247
5. THE ADMINISTRATION OF OXYTOCIN HAS BEEN PROPOSED AS A TREATMENT FOR AUTISM.
